Prospeo
Hero Section BackgroundHero Section Background
Aldagen, Inc

Aldagen, Inc Email Formats

Biotechnology ResearchFlag of USUnited States1-10 Employees

Key Contact at Aldagen, Inc

Flag of US

Gary Vinson

director, qa

Company overview

HeadquartersUnited States
Phone number+12404992680
Website
NAICS541714
Keywords
Stem Cell Therapeutics
Founded2001
Employees1-10
Socials

About Aldagen, Inc

Aldagen is a wholly-owned subsidiary of Cytomedix, Inc (BB:CMXI). The Aldagen subsidiary develops proprietary regenerative cell therapies in the vascular area. These cell therapeutics consist of a specific population of stem cells from a patient’s own bone marrow. Aldagen isolates these cells, which are typically less than 1% of all cells in bone marrow, using our proprietary technology. Based on preclinical studies and our clinical trials to date, Aldagen believes these cell populations have the potential to promote the regeneration of multiple types of cells and tissues, including the growth of new blood vessels, a process known as angiogenesis. Aldagen's product candidates are ALD-301 for the treatment of critical limb ischemia, ALD-201 for the treatment of ischemic heart failure and ALD-401 for the treatment of ischemic stroke.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Aldagen, Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2012-02-1312$585,000

Funding Insights

$585,000

Total funding amount

$585,000

Most recent funding amount

1

Number of funding rounds

Frequently asked questions

Aldagen, Inc is located in US.
You can reach Aldagen, Inc at +12404992680.
Aldagen, Inc was founded in 2001, making it 25 years old. The company has established itself as a significant player in its industry over this time.
Aldagen, Inc has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Aldagen, Inc has raised a total of $585,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles